Letter to the Editor: Advancing induced pluripotent stem cell-derived mesenchymal stem cells - insights from comparative differentiation protocols and emerging innovations

Induced pluripotent stem cell-derived mesenchymal stem cells (iMSCs) depict a transformative tool in regenerative medicine, offering scalable, patient-specific alternatives to primary mesenchymal stem cells. The recent study by Ababneh et al published in the World Journal of Stem Cells provides a comprehensive comparison of five differentiation protocols, highlighting protocol-dependent variations in iMSC functionality. This article discusses the key findings, their implications for standardizat